Cancer Research Annual Meeting 2010 Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rudland, P. S.
Right arrow Articles by West, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rudland, P. S.
Right arrow Articles by West, C. R.
[Cancer Research 62, 3417-3427, June 15, 2002]
© 2002 American Association for Cancer Research

Clinical Investigations

Prognostic Significance of the Metastasis-associated Protein Osteopontin in Human Breast Cancer1

Philip S. Rudland2, Angela Platt-Higgins, Mohamed El-Tanani, Suzete de Silva Rudland, Roger Barraclough, John H. R. Winstanley3, Rachel Howitt4 and Christopher R. West

Cancer and Polio Research Fund Laboratories, School of Biological Sciences [P. S. R., A. P-H., M. E-T., S. d. S. R., R. B.], Cancer Tissue Bank Research Centre [P. S. R.], Department of Pathology [R. H.], and Department of Public Health [C. R. W.], University of Liverpool, and Breast Unit, Royal Liverpool University Hospital [J. H. R. W.], Liverpool, L69 3BX, United Kingdom

The adhesive glycophosphoprotein (OPN) is capable of inducing metastasis in rodent models ofbreast cancer. We now show that a monoclonal antibody to rat OPN recognizes specifically human OPN using Western blotting techniques andused it to assess the prognostic significance of OPN in primary tumors of a group of 333 patients treated between 1976 and 1982 for operable stage I and stage II breast cancer. The antibody stains immunocytochemically normal breast tissue weakly but pregnant/lactating tissue and 66% of the carcinomas strongly, leaving the remaining 34% as negatively stained. In addition to the carcinoma cells, some host reactive stromal cells, macrophages, lymphocytes, and blood vessels are also stained, but these have been excluded in the following analyses. There is a significant association of staining of carcinomas for OPN with some tumor variables reported previously to be associated with patient outcome: high histological grade (P = 0.024), staining for c-erbB-3 (P < 0.001), p53 (P = 0.014), pS2 (P = 0.025), and borderline significance for progesterone receptor (P = 0.089). The association of staining for OPN with survival times of the patients has been evaluated using life tables over 14–20 years of follow-up (mean 16 years) and analyzed using generalized Wilcoxon statistics. Of the patients who have been classified as OPN-negative, 94% are alive, but only 26% of those classified as OPN-positive are alive after 19 years of follow-up. This association is highly significant (P < 0.0001); the former have a median survival of >228 months and the latter 68 months. When the patients are divided into separate classes based on the percentage of carcinoma cells staining for OPN, the five classes show a progressive decrease in survival with increasing percentage of stained carcinoma cells, and this association is also highly significant (P < 0.0001). Other tumor variables that show a significant association with patient survival times in this group of patients include nodal status, tumor size, histological grade, staining for c-erbB-2, estrogen receptor {alpha}, or p53. Analysis of the association of patients with carcinomas staining for OPN and their survival in subgroups defined by these tumor variables shows that positive staining for OPN in each subgroup is associated with poorer survival. There is little difference in patient survival times in the OPN-negative group of patients with or without any of the other tumor variables examined. Multivariate regression analysis for 202 patients shows that staining for OPN is most highly correlated with patients’ deaths (P < 0.0001), but involved lymph nodes (P = 0.0007), fixed tumors (P = 0.0008), and staining for estrogen receptor {alpha} (P = 0.008) are also significant independent prognostic variables with that for c-erbB-2 being of borderline significance (P = 0.060). These results suggest that in this group of patients, the presence of the metastasis-associated protein OPN is tightly correlated with patient demise.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
D. L. Barraclough, A. Platt-Higgins, S. de Silva Rudland, R. Barraclough, J. Winstanley, C. R. West, and P. S. Rudland
The Metastasis-Associated Anterior Gradient 2 Protein Is Correlated with Poor Survival of Breast Cancer Patients
Am. J. Pathol., November 1, 2009; 175(5): 1848 - 1857.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. J. Caruso, A. J.K. Carmack, V. B. Lokeshwar, R. C. Duncan, M. S. Soloway, and B. L. Lokeshwar
Osteopontin and Interleukin-8 Expression is Independently Associated with Prostate Cancer Recurrence
Clin. Cancer Res., July 1, 2008; 14(13): 4111 - 4118.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. K. Mason, S. McFarlane, P. G. Johnston, P. Crowe, P. J. Erwin, M. M. Domostoj, F. C. Campbell, S. Manaviazar, K. J. Hale, and M. El-Tanani
Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation
Mol. Cancer Ther., March 1, 2008; 7(3): 548 - 558.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Suzuki, E. Mose, C. Galloy, and D. Tarin
Osteopontin Gene Expression Determines Spontaneous Metastatic Performance of Orthotopic Human Breast Cancer Xenografts
Am. J. Pathol., August 1, 2007; 171(2): 682 - 692.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson
The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1087 - 1097.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Cheng, D.-H. Huo, D.-M. Kuang, J. Yang, L. Zheng, and S.-M. Zhuang
Human Macrophages Promote the Motility and Invasiveness of Osteopontin-Knockdown Tumor Cells
Cancer Res., June 1, 2007; 67(11): 5141 - 5147.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. K. El-Tanani, F. C. Campbell, P. Crowe, P. Erwin, D. P. Harkin, P. Pharoah, B. Ponder, and P. S. Rudland
BRCA1 Suppresses Osteopontin-mediated Breast Cancer
J. Biol. Chem., September 8, 2006; 281(36): 26587 - 26601.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. L. Allan, R. George, S. A. Vantyghem, M. W. Lee, N. C. Hodgson, C. J. Engel, R. L. Holliday, D. P. Girvan, L. A. Scott, C. O. Postenka, et al.
Role of the Integrin-Binding Protein Osteopontin in Lymphatic Metastasis of Breast Cancer
Am. J. Pathol., July 1, 2006; 169(1): 233 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. H.C. Bramwell, G. S. Doig, A. B. Tuck, S. M. Wilson, K. S. Tonkin, A. Tomiak, F. Perera, T. A. Vandenberg, and A. F. Chambers
Serial plasma osteopontin levels have prognostic value in metastatic breast cancer.
Clin. Cancer Res., June 1, 2006; 12(11): 3337 - 3343.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
M Burkhardt, E Mayordomo, K-J Winzer, F Fritzsche, T Gansukh, S Pahl, W Weichert, C Denkert, H Guski, M Dietel, et al.
Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer
J. Clin. Pathol., April 1, 2006; 59(4): 403 - 409.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. R. Fritzsche, E. Dahl, S. Pahl, M. Burkhardt, J. Luo, E. Mayordomo, T. Gansukh, A. Dankof, R. Knuechel, C. Denkert, et al.
Prognostic Relevance of AGR2 Expression in Breast Cancer.
Clin. Cancer Res., March 15, 2006; 12(6): 1728 - 1734.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Q.-T. Le, E. Chen, A. Salim, H. Cao, C. S. Kong, R. Whyte, J. Donington, W. Cannon, H. Wakelee, R. Tibshirani, et al.
An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non-Small Cell Lung Cancers
Clin. Cancer Res., March 1, 2006; 12(5): 1507 - 1514.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. de Silva Rudland, L. Martin, C. Roshanlall, J. Winstanley, S. Leinster, A. Platt-Higgins, J. Carroll, C. West, R. Barraclough, and P. Rudland
Association of S100A4 and Osteopontin with Specific Prognostic Factors and Survival of Patients with Minimally Invasive Breast Cancer
Clin. Cancer Res., February 15, 2006; 12(4): 1192 - 1200.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Ito, Y. Hashimoto, E. Tanaka, T. Kan, S. Tsunoda, F. Sato, M. Higashiyama, T. Okumura, and Y. Shimada
An Inducible Short-Hairpin RNA Vector against Osteopontin Reduces Metastatic Potential of Human Esophageal Squamous Cell Carcinoma In vitro and In vivo
Clin. Cancer Res., February 15, 2006; 12(4): 1308 - 1316.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Wang, A. Platt-Higgins, J. Carroll, S. de Silva Rudland, J. Winstanley, R. Barraclough, and P. S. Rudland
Induction of Metastasis by S100P in a Rat Mammary Model and Its Association with Poor Survival of Breast Cancer Patients
Cancer Res., January 15, 2006; 66(2): 1199 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Z. Hu, D. Lin, J. Yuan, T. Xiao, H. Zhang, W. Sun, N. Han, Y. Ma, X. Di, M. Gao, et al.
Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non-Small Cell Lung Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 4646 - 4652.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Liu, P. S. Rudland, D. R. Sibson, A. Platt-Higgins, and R. Barraclough
Human Homologue of Cement Gland Protein, a Novel Metastasis Inducer Associated with Breast Carcinomas
Cancer Res., May 1, 2005; 65(9): 3796 - 3805.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A Martinetti, E Bajetta, L Ferrari, N Zilembo, E Seregni, M Del Vecchio, R Longarini, I La Torre, L Toffolatti, D Paleari, et al.
Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole
Endocr. Relat. Cancer, December 1, 2004; 11(4): 771 - 779.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. El-Tanani, A. Platt-Higgins, P. S. Rudland, and F. C. Campbell
Ets Gene PEA3 Cooperates with {beta}-Catenin-Lef-1 and c-Jun in Regulation of Osteopontin Transcription
J. Biol. Chem., May 14, 2004; 279(20): 20794 - 20806.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Koopmann, N. S. Fedarko, A. Jain, A. Maitra, C. Iacobuzio-Donahue, A. Rahman, R. H. Hruban, C. J. Yeo, and M. Goggins
Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma
Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 487 - 491.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
S. Schneider, J. Yochim, J. Brabender, K. Uchida, K. D. Danenberg, R. Metzger, P. M. Schneider, D. Salonga, A. H. Holscher, and P. V. Danenberg
Osteopontin But Not Osteonectin Messenger RNA Expression Is a Prognostic Marker in Curatively Resected Non-Small Cell Lung Cancer
Clin. Cancer Res., March 1, 2004; 10(5): 1588 - 1596.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. E. Korkola, S. DeVries, J. Fridlyand, E. S. Hwang, A. L. H. Estep, Y.-Y. Chen, K. L. Chew, S. H. Dairkee, R. M. Jensen, and F. M. Waldman
Differentiation of Lobular versus Ductal Breast Carcinomas by Expression Microarray Analysis
Cancer Res., November 1, 2003; 63(21): 7167 - 7175.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
P.-L. Chang, M. Cao, and P. Hicks
Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells
Carcinogenesis, November 1, 2003; 24(11): 1749 - 1758.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Kristiansen, K.-J. Winzer, E. Mayordomo, J. Bellach, K. Schluns, C. Denkert, E. Dahl, C. Pilarsky, P. Altevogt, H. Guski, et al.
CD24 Expression Is a New Prognostic Marker in Breast Cancer
Clin. Cancer Res., October 15, 2003; 9(13): 4906 - 4913.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
G. Zhang, B. He, and G. F. Weber
Growth Factor Signaling Induces Metastasis Genes in Transformed Cells: Molecular Connection between Akt Kinase and Osteopontin in Breast Cancer
Mol. Cell. Biol., September 15, 2003; 23(18): 6507 - 6519.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
K. A. Furger, A. L. Allan, S. M. Wilson, C. Hota, S. A. Vantyghem, C. O. Postenka, W. Al-Katib, A. F. Chambers, and A. B. Tuck
{beta}3 Integrin Expression Increases Breast Carcinoma Cell Responsiveness to the Malignancy-Enhancing Effects of Osteopontin
Mol. Cancer Res., September 1, 2003; 1(11): 810 - 819.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.